↓ Skip to main content
What is this page? Embed badge

Portal Hypertension VII

Overview of attention for book
Cover of 'Portal Hypertension VII'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction: Baveno I to Baveno VII … and Beyond
  3. Altmetric Badge
    Chapter 2 New Concepts in Risk Stratification
  4. Altmetric Badge
    Chapter 3 Clinical Stages and Ordinal Outcomes in Portal Hypertension
  5. Altmetric Badge
    Chapter 4 Lifestyle and Genetic Modifiers of Liver Disease Progression
  6. Altmetric Badge
    Chapter 5 HVPG as a Gold Standard: Accuracy Is Essential
  7. Altmetric Badge
    Chapter 6 HVPG as a Gold Standard: Consensus Statements of Panel 1
  8. Altmetric Badge
    Chapter 7 Results of the Baveno VII Questionnaire on the Use of Noninvasive Tools for cACLD and Portal Hypertension
  9. Altmetric Badge
    Chapter 8 Compensated Advanced Chronic Liver Disease (cACLD)
  10. Altmetric Badge
    Chapter 9 Noninvasive Detection of Clinically Significant Portal Hypertension with Liver Elastography
  11. Altmetric Badge
    Chapter 10 Varices and Screening Endoscopy
  12. Altmetric Badge
    Chapter 11 Liver Elastography for Prognostication and Monitoring Patients With Compensated Advanced Chronic Liver Disease
  13. Altmetric Badge
    Chapter 12 Spleen Stiffness
  14. Altmetric Badge
    Chapter 13 Emerging Non-invasive Markers: Imaging, Blood, and Liver Clearance Tests
  15. Altmetric Badge
    Chapter 14 Noninvasive Surrogates for cACLD, CSPH, Varices: Consensus Statements of Panel 2
  16. Altmetric Badge
    Chapter 15 Progression and Regression of Cirrhosis: The Histologic Perspective
  17. Altmetric Badge
    Chapter 16 Liver Fibrosis and Its Regression in the Context of Portal Hypertension
  18. Altmetric Badge
    Chapter 17 Angiogenesis and Progression of ACLD
  19. Altmetric Badge
    Chapter 18 Drugs to Modify Liver Fibrosis Progression and Regression
  20. Altmetric Badge
    Chapter 19 Therapies for Alcohol-Related Liver Disease and for Non-Alcoholic Fatty Liver Disease
  21. Altmetric Badge
    Chapter 20 Management of ACLD After HBV-Suppression and HCV-Cure
  22. Altmetric Badge
    Chapter 21 Management of ACLD After Removal/Suppression of the Etiological Factor: Consensus Statements of Panel 3
  23. Altmetric Badge
    Chapter 22 Results of the Baveno VII Questionnaire on the “Impact of Non-etiological Therapies in the Course of Cirrhosis”
  24. Altmetric Badge
    Chapter 23 Statins in Compensated and Decompensated Cirrhosis: Approaching the Bedside
  25. Altmetric Badge
    Chapter 24 Anticoagulation for Portal Vein Thrombosis in Cirrhosis: An Evidence-Based Approach to When and How
  26. Altmetric Badge
    Chapter 25 Novel Approaches and Disease Modifiers to Alter the Course of Cirrhotic Portal Hypertension
  27. Altmetric Badge
    Chapter 26 Targeting the Gut Microbiome in Cirrhosis
  28. Altmetric Badge
    Chapter 27 Impact of Non-etiological Novel Therapies in the Course of Cirrhosis: Consensus Statements of Panel 4
  29. Altmetric Badge
    Chapter 28 Prevention of First Decompensation: Questionnaire
  30. Altmetric Badge
    Chapter 29 Definition of First Decompensation in Cirrhosis
  31. Altmetric Badge
    Chapter 30 Evaluation of the Impact of the Sole Presence of Infection (Without Accompanying Decompensation) in the Natural History of Compensated Cirrhosis
  32. Altmetric Badge
    Chapter 31 Evaluation of the Role of Jaundice in the Definition of Decompensation in the Compensated Patients
  33. Altmetric Badge
    Chapter 32 Evaluation of the Role of Minimal Perihepatic Ascites, Minimal Hepatic Encephalopathy, and Bleeding Due to Portal Hypertensive Gastroenteropathy in the Definition of Decompensation
  34. Altmetric Badge
    Chapter 33 Evaluation of the Role of Sarcopenia in the Definition of Decompensation of the Compensated Patient
  35. Altmetric Badge
    Chapter 34 β-Blockers to Prevent Decompensation of Cirrhosis in Compensated Patients With Clinically Significant Portal Hypertension
  36. Altmetric Badge
    Chapter 35 Evaluation of the Effect of CSPH, Reduction of HVPG, and Other Factors Predicting the First Decompensation in Cirrhosis
  37. Altmetric Badge
    Chapter 36 Preventing (First) Decompensation: Consensus Statements of Panel 5
  38. Altmetric Badge
    Chapter 37 General Management of Acute Variceal Bleeding
  39. Altmetric Badge
    Chapter 38 Risk Stratification and Prognostic Factors in Variceal Bleeding
  40. Altmetric Badge
    Chapter 39 Endoscopic Management: Classic and New Therapies
  41. Altmetric Badge
    Chapter 40 Preemptive TIPS (p-TIPS)
  42. Altmetric Badge
    Chapter 41 Management of Refractory Variceal Bleeding
  43. Altmetric Badge
    Chapter 42 Hepatic Encephalopathy and Acute Variceal Bleeding
  44. Altmetric Badge
    Chapter 43 Management of Coagulation in Acute Variceal Bleeding
  45. Altmetric Badge
    Chapter 44 Gastric Varices and Ectopic Varices
  46. Altmetric Badge
    Chapter 45 Special Settings: Acute Variceal Bleeding and Portal Vein Thrombosis in Cirrhosis
  47. Altmetric Badge
    Chapter 46 Clinical Settings 2: Acute Variceal Bleeding—Consensus Statements of Panel 6
  48. Altmetric Badge
    Chapter 47 Concept of Further Decompensation and Recompensation
  49. Altmetric Badge
    Chapter 48 Prevention of Variceal Bleeding and Rebleeding
  50. Altmetric Badge
    Chapter 49 Prevention of Further Decompensation in Patients With Ascites
  51. Altmetric Badge
    Chapter 50 The Impact of Sarcopenia, Frailty, and Malnutrition on Further Decompensation
  52. Altmetric Badge
    Chapter 51 Preventing Further Decompensation: Consensus Statements of Panel 7
  53. Altmetric Badge
    Chapter 52 Portal Vein Thrombosis: Anticoagulation Vs. Interventional Radiology
  54. Altmetric Badge
    Chapter 53 Staging of Portal Vein Thrombosis: Recurrent Thrombosis and Prognostic Factors for Recurrence in Non-Cirrhotic Non-Tumoral Portal Vein Thrombosis (PVT)
  55. Altmetric Badge
    Chapter 54 Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
  56. Altmetric Badge
    Chapter 55 Splanchnic Vein Thrombosis: Consensus Statements of Panel 8
  57. Altmetric Badge
    Chapter 56 Porto-Sinusoidal Vascular Disorder
  58. Altmetric Badge
    Chapter 57 Anticoagulation in Splanchnic Vein Thrombosis With and Without Underlying Liver Disease
  59. Altmetric Badge
    Chapter 58 Medical Approach to Fontan Patients
  60. Altmetric Badge
    Chapter 59 Other Issues in Vascular Liver Disorders: Consensus Statements of Panel 9
Attention for Chapter 57: Anticoagulation in Splanchnic Vein Thrombosis With and Without Underlying Liver Disease
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
48 Dimensions
Summary X Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Anticoagulation in Splanchnic Vein Thrombosis With and Without Underlying Liver Disease
Chapter number 57
Book title
Portal Hypertension VII
Published by
Springer, Cham, January 2022
DOI 10.1007/978-3-031-08552-9_57
Book ISBNs
978-3-03-108551-2, 978-3-03-108552-9
Authors

Senzolo, Marco, Zanetto, Alberto

View on publisher site
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

This page is provided by Altmetric.